Scientific Advisory Board
TTi's Slogan
Keelung Hong, Ph.D.
- Founded Taiwan Liposome Company (TLC) and served as Chairman of the board of directors, Chief Executive Officer and Science and Technology Adviser.
- Co-founded Hermes Biosciences, Inc. and served as its Chief Scientific Officer.
- Research Scientist for the California Pacific Medical Center Research Institute.
- Scientist at the Liposome Research Laboratory at the Cancer Research Institute of the University of California, San Francisco.
- Served as a consultant to various biopharmaceutical companies over the years.
- Ph.D. in Chemistry from the University of California, Berkeley.
Cheng-wen Wu, M.D., Ph.D.
- Academician of Taiwan Academia Sinica.
- Founding president of National Health Research Institutes.
- Special lecturer at National Yang-Ming University.
- President, International Federation for Cell Biology, 2004 - 2008.
- Founding President, Asian Conference on Transcription.
- Ph.D. from the University of Case Western Reserve.
Alice L. Yu, M.D., Ph.D.
- Academician of Taiwan Academia Sinica.
- Distinguished Chair Professor & Deputy Director of the Institute of Stem Cell & Translational Cancer Research at Chang Gung Memorial Hospital & Chang Gung University.
- Professor Emeritus of Pediatrics at the University of California in San Diego.
- Distinguished Research Fellow and Associate Director at the Genomics Research Center, Academia Sinica, in Taiwan.
- A long-time member of the Children's Oncology Group in the United States, serving on the Steering Committee of Neuroblastoma.
- A pioneer in cancer immunotherapy, Dr. Yu has taken an anti-GD2 monoclonal antibody from preclinical to Phase III clinical trial, culminating in its FDA approval in 2015.
- Ph.D. in Microbiology/Immunology from the University of Chicago.